Interestingly, in our recent study, both Aß-specific IgG and IgM levels are found to be increased in hyperglycemia as well as in AD, suggesting that Aß peptides may be a general target and responds varyingly in metabolic disorder [18]. Here, CD40LG is linked to Alzheimer disease.